Louise Duffy is focused on the scientific and technical aspects associated with Abzena’s portfolio from early development to commercial production.
Louise is responsible for leading and driving Abzena’s technical CMC strategy, providing technical and CMC regulatory leadership and guidance to project teams while working collaboratively with clients for project success.
With a career spanning over 30 years, Louise has deep expertise in the development, technology transfer, and supply of biopharmaceuticals, vaccines, and cell & gene therapies. She has in-depth experience in the development of strategic CMC approaches to support successful global regulatory inspections and filings such as INDs, IMPDs, BLA, and MAAs.
Prior to joining Abzena in 2020 she was an independent consultant in biopharmaceuticals and cell and gene therapies and has held senior leadership roles in GlaxoSmithKline as VP & Global Supply Chain Head, Biopharmaceuticals and Janssen R&D (J&J) as VP & Global Head, Strategic Sciences.
Louise contributes and speaks at organizations including BioPhorum, PDA and ISPE. Louise is on multiple scientific advisory panels.
Louise holds a Ph.D. and a M.Sc. in Chemical Engineering from Imperial College, London, and a B.Sc. in Chemistry and Biochemistry from the University of British Columbia, Vancouver, Canada.